Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
-
* Corresponding authors: Jacques Tebib jacques.tebib@chu-lyon.fr - Olivier Hermine ohermine@gmail.com
Arthritis Research & Therapy 2009, 11:R95 doi:10.1186/ar2740
Accesses
- Last 30 days: 214 accesses
- Last year: 2088 accesses
- All time: 10494 accesses
Cited by
BioMed Central: 1 citation
|
Ulrich A Walker Arthritis Research & Therapy 2009, 11:120 (13 July 2009) |